(NEU) NewMarket - Ratings and Ratios
Lubricant Additives, Fuel Additives, Antiknock Compounds
NEU EPS (Earnings per Share)
NEU Revenue
Description: NEU NewMarket
NewMarket Corporation is a leading manufacturer and supplier of petroleum additives, catering to various industries including automotive, industrial, and fuel sectors. The companys product portfolio includes lubricant additives, engine oil additives, driveline additives, and industrial additives, as well as fuel additives that enhance the performance of gasoline, diesel, and biofuels.
With a global presence spanning across North America, Latin America, Asia Pacific, Europe, the Middle East, Africa, and India, NewMarket Corporation has established itself as a significant player in the specialty chemicals industry. The companys extensive geographical reach enables it to serve a diverse customer base, including original equipment manufacturers, industry players, government agencies, and individual customers.
To further evaluate the companys performance, we can examine key performance indicators (KPIs) such as revenue growth, gross margin, and return on equity (ROE). With a ROE of 34.45%, NewMarket Corporation demonstrates a strong ability to generate profits from shareholder equity. Additionally, the companys market capitalization of $6.89 billion indicates a significant market presence. Other relevant KPIs could include the companys dividend yield, payout ratio, and debt-to-equity ratio, which can provide insights into its financial health and sustainability.
From a business perspective, NewMarket Corporations diversified product portfolio and global reach position it well for long-term growth. The increasing demand for high-performance lubricants and fuels, driven by the growing automotive and industrial sectors, is likely to benefit the company. Furthermore, the companys focus on research and development, as evident from its product innovations, is expected to drive future growth and expansion.
NEU Stock Overview
| Market Cap in USD | 7,524m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception | 1985-08-06 |
NEU Stock Ratings
| Growth Rating | 81.0% |
| Fundamental | 84.9% |
| Dividend Rating | 60.1% |
| Return 12m vs S&P 500 | 26.8% |
| Analyst Rating | - |
NEU Dividends
| Dividend Yield 12m | 1.93% |
| Yield on Cost 5y | 3.97% |
| Annual Growth 5y | 5.64% |
| Payout Consistency | 81.7% |
| Payout Ratio | 26.0% |
NEU Growth Ratios
| Growth Correlation 3m | 86.1% |
| Growth Correlation 12m | 76.6% |
| Growth Correlation 5y | 76.1% |
| CAGR 5y | 19.98% |
| CAGR/Max DD 5y | 0.63 |
| Sharpe Ratio 12m | 0.71 |
| Alpha | 41.31 |
| Beta | 0.436 |
| Volatility | 21.14% |
| Current Volume | 125.7k |
| Average Volume 20d | 75.3k |
| Stop Loss | 802.1 (-3%) |
| Signal | 0.85 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (480.3m TTM) > 0 and > 6% of Revenue (6% = 166.7m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 0.86pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.96% (prev 25.60%; Δ -1.65pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 583.2m > Net Income 480.3m (YES >=105%, WARN >=100%) |
| Net Debt (848.1m) to EBITDA (781.6m) ratio: 1.09 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (9.40m) change vs 12m ago -1.72% (target <= -2.0% for YES) |
| Gross Margin 32.69% (prev 29.94%; Δ 2.75pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 87.60% (prev 86.27%; Δ 1.34pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 14.02 (EBITDA TTM 781.6m / Interest Expense TTM 47.2m) >= 6 (WARN >= 3) |
Altman Z'' 5.41
| (A) 0.21 = (Total Current Assets 1.07b - Total Current Liabilities 402.1m) / Total Assets 3.19b |
| (B) 0.48 = Retained Earnings (Balance) 1.54b / Total Assets 3.19b |
| (C) 0.21 = EBIT TTM 662.5m / Avg Total Assets 3.17b |
| (D) 1.02 = Book Value of Equity 1.61b / Total Liabilities 1.58b |
| Total Rating: 5.41 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.87
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 6.32% = 3.16 |
| 3. FCF Margin 18.89% = 4.72 |
| 4. Debt/Equity 0.53 = 2.36 |
| 5. Debt/Ebitda 1.10 = 1.62 |
| 6. ROIC - WACC 14.37% = 12.50 |
| 7. RoE 32.25% = 2.50 |
| 8. Rev. Trend 12.11% = 0.61 |
| 9. Rev. CAGR 0.13% = 0.02 |
| 10. EPS Trend 75.40% = 1.88 |
| 11. EPS CAGR 25.46% = 2.50 |
What is the price of NEU shares?
Over the past week, the price has changed by +3.80%, over one month by +20.26%, over three months by +30.56% and over the past year by +48.28%.
Is NewMarket a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NEU is around 907.99 USD . This means that NEU is currently overvalued and has a potential downside of 9.8%.
Is NEU a buy, sell or hold?
What are the forecasts/targets for the NEU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 450 | -45.6% |
| Analysts Target Price | 450 | -45.6% |
| ValueRay Target Price | 998.3 | 20.7% |
Last update: 2025-08-23 05:04
NEU Fundamental Data Overview
CCE Cash And Equivalents = 70.3m USD (last quarter)
P/E Trailing = 15.8743
P/S = 2.7074
P/B = 4.613
P/EG = 5.09
Beta = 0.468
Revenue TTM = 2.78b USD
EBIT TTM = 662.5m USD
EBITDA TTM = 781.6m USD
Long Term Debt = 841.8m USD (from longTermDebt, last quarter)
Short Term Debt = 17.2m USD (from shortTermDebt, last quarter)
Debt = 859.0m USD (Calculated: Short Term 17.2m + Long Term 841.8m)
Net Debt = 848.1m USD (from netDebt column, last quarter)
Enterprise Value = 8.31b USD (7.52b + Debt 859.0m - CCE 70.3m)
Interest Coverage Ratio = 14.02 (Ebit TTM 662.5m / Interest Expense TTM 47.2m)
FCF Yield = 6.32% (FCF TTM 525.1m / Enterprise Value 8.31b)
FCF Margin = 18.89% (FCF TTM 525.1m / Revenue TTM 2.78b)
Net Margin = 17.28% (Net Income TTM 480.3m / Revenue TTM 2.78b)
Gross Margin = 32.69% ((Revenue TTM 2.78b - Cost of Revenue TTM 1.87b) / Revenue TTM)
Tobins Q-Ratio = 5.16 (Enterprise Value 8.31b / Book Value Of Equity 1.61b)
Interest Expense / Debt = 1.25% (Interest Expense 10.7m / Debt 859.0m)
Taxrate = 20.83% (from yearly Income Tax Expense: 121.7m / 584.1m)
NOPAT = 524.4m (EBIT 662.5m * (1 - 20.83%))
Current Ratio = 2.66 (Total Current Assets 1.07b / Total Current Liabilities 402.1m)
Debt / Equity = 0.53 (Debt 859.0m / last Quarter total Stockholder Equity 1.61b)
Debt / EBITDA = 1.10 (Net Debt 848.1m / EBITDA 781.6m)
Debt / FCF = 1.64 (Debt 859.0m / FCF TTM 525.1m)
Total Stockholder Equity = 1.49b (last 4 quarters mean)
RoA = 15.03% (Net Income 480.3m, Total Assets 3.19b )
RoE = 32.25% (Net Income TTM 480.3m / Total Stockholder Equity 1.49b)
RoCE = 28.42% (Ebit 662.5m / (Equity 1.49b + L.T.Debt 841.8m))
RoIC = 21.31% (NOPAT 524.4m / Invested Capital 2.46b)
WACC = 6.94% (E(7.52b)/V(8.38b) * Re(7.62%)) + (D(859.0m)/V(8.38b) * Rd(1.25%) * (1-Tc(0.21)))
Shares Correlation 5-Years: -100.0 | Cagr: -2.57%
Discount Rate = 7.62% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 78.41% ; FCFE base≈511.4m ; Y1≈515.7m ; Y5≈556.6m
Fair Price DCF = 1046 (DCF Value 9.83b / Shares Outstanding 9.40m; 5y FCF grow 0.43% → 3.0% )
Revenue Correlation: 12.11 | Revenue CAGR: 0.13%
Rev Growth-of-Growth: 3.01
EPS Correlation: 75.40 | EPS CAGR: 25.46%
EPS Growth-of-Growth: -9.59
Additional Sources for NEU Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle